Cargando…

How Do We Explore Heterogeneity in Turnover of Musculoskeletal Proteins?

Detalles Bibliográficos
Autores principales:	Agergaard, Jakob, Kjær, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788750/ https://www.ncbi.nlm.nih.gov/pubmed/35330620 http://dx.doi.org/10.1093/function/zqab034

Ejemplares similares

Malaria: How Are We Doing and How Can We Do Better?
por: Rosenthal, Philip J., et al.
Publicado: (2019)

Management of Cryptococcosis: How Are We Doing?
por: Perfect, John R
Publicado: (2007)

How Do We “Validate” a QSP Model?
por: Kirouac, Daniel C.
Publicado: (2018)

In medicine, how do we machine learn anything real?
por: Ghassemi, Marzyeh, et al.
Publicado: (2022)

Public Data Archiving in Ecology and Evolution: How Well Are We Doing?
por: Roche, Dominique G., et al.
Publicado: (2015)

Modern Compact Cities: How Much Greenery Do We Need?
por: Russo, Alessio, et al.
Publicado: (2018)

How do we teach surgical residents in the COVID-19 era?
por: Okland, Tyler S., et al.
Publicado: (2020)

Moving toward multimedia electronic health records: how do we get there?
por: Seto, Belinda, et al.
Publicado: (2012)

Endosomal escape of RNA therapeutics: How do we solve this rate-limiting problem?
por: Dowdy, Steven F.
Publicado: (2023)

Insect Cultural Services: How Insects Have Changed Our Lives and How Can We Do Better for Them
por: Duffus, Natalie E., et al.
Publicado: (2021)

Visitation restrictions: is it right and how do we support families in the NICU during COVID-19?
por: Murray, Peter D., et al.
Publicado: (2020)

Tackling Loneliness and Isolation in Older Adults With Virtual Reality: How do We Move Forward?
por: Finnegan, Daniel J., et al.
Publicado: (2023)

Do we face a third revolution in human history? If so, how will public health respond?
por: Hanlon, Phil, et al.
Publicado: (2008)

Evaluating how we evaluate
por: Vale, Ronald D.
Publicado: (2012)

How do protein domains of low sequence complexity work?
por: Kato, Masato, et al.
Publicado: (2022)

How Do We Combat Bogus Medicines in the Age of the COVID-19 Pandemic?
por: Tesfaye, Wubshet, et al.
Publicado: (2020)

How do we prepare ourselves for a new paradigm of medicine to advance the treatment of pediatric acute lymphoblastic leukemia?
por: Park, Kyung Duk
Publicado: (2014)

Do We Need to Use Bats as Bioindicators?
por: Russo, Danilo, et al.
Publicado: (2021)

Do We Need Biomarkers for Disc Degeneration?
por: Gruber, Helen E., et al.
Publicado: (2007)

Do we need a new levodopa?
por: Müller, Thomas
Publicado: (2016)

Exploring genes that control microglial heterogeneity and transition
por: Okajima, Tomomi, et al.
Publicado: (2021)

How do we forecast tomorrow’s transfusion? Prehospital transfusion
por: Yazer, Mark H., et al.
Publicado: (2023)

Integrating blue: How do we make nationally determined contributions work for both blue carbon and local coastal communities?
por: Dencer-Brown, Amrit Melissa, et al.
Publicado: (2022)

Point-of-care screening for atrial fibrillation: Where are we, and where do we go next?
por: Ashburner, Jeffrey M., et al.
Publicado: (2021)

Musculoskeletal research in human space flight – unmet needs for the success of crewed deep space exploration
por: Liphardt, Anna-Maria, et al.
Publicado: (2023)

How do I/we forecast tomorrows’ transfusion: Blood components
por: Pereyra, Nicolas, et al.
Publicado: (2023)

How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?
por: Haller, Michael J., et al.
Publicado: (2021)

How do we learn about improving health care: a call for a new epistemological paradigm
por: Massoud, M. Rashad, et al.
Publicado: (2016)

Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
por: Qi, Luo, et al.
Publicado: (2022)

COVID toes: where do we stand with the current evidence?
por: Baeck, Marie, et al.
Publicado: (2021)

What Do We Know About Remdesivir Drug Interactions?
por: Yang, Katherine
Publicado: (2020)

Why are people antiscience, and what can we do about it?
por: Philipp-Muller, Aviva, et al.
Publicado: (2022)

How should we be selecting our graduate students?
por: Weiner, Orion D.
Publicado: (2014)

Health Literacy and People with Intellectual Disabilities: What We Know, What We Do Not Know, and What We Need: A Theoretical Discourse
por: Geukes, Cornelia, et al.
Publicado: (2019)

FDG-PET/CT in Lymphoma: Where Do We Go Now?
por: Al Tabaa, Yassine, et al.
Publicado: (2021)

Health insurance system for hematologic diseases: what should we do?
por: Jang, Moon Ju, et al.
Publicado: (2011)

Why aren’t we doing better in asthma: time for personalised medicine?
por: Thomas, Mike
Publicado: (2015)

The Impasse on Overall Survival in Oncology Reimbursement Decision-Making: How Can We Resolve This?
por: Lux, Michael Patrick, et al.
Publicado: (2021)

How We Review a Medical Education Research Manuscript
por: Hayes, Margaret M., et al.
Publicado: (2021)

The Middle East Respiratory Syndrome—How Worried Should We Be?
por: Perlman, Stanley
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hga5esm9olt9ihoinb6h850f2m